The Global Impact of COVID-19 on TB and HIV Services in LMICs
An online survey of 669 frontline professionals from 64 countries conducted by the London School of Hygiene & Tropical Medicine (LSHTM) TB Centre identified specific impacts of COVID-19 on tuberculosis (TB) and HIV services in low- and middle-income countries (LMICs) and actions to address disruptions
TB and HIV are the two infectious diseases that cause the highest number of deaths globally.
The disruption to essential healthcare provision caused by COVID-19 could lead to a dramatic increase in the number of deaths per annum.
Therefore, policies to minimise disruptions to TB and HIV care must be put in place urgently.
Information from frontline health professionals and researchers is invaluable in understanding the range of impacts of COVID-19 on TB and HIV services and identifying feasible strategies for mitigation.
Our survey collected quantitative and qualitative data from 669 TB and HIV healthcare delivery, management and research professionals in 64 LMICs around the world.
The survey was available from May 12 to August 6 2020 in 11 languages: Arabic, Bahasa, Chinese, English, French, Portuguese, Russian, Shona, Spanish, Swahili, and Urdu.